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Abstract: We report on a patient with hypovitaminosis A treated with autologous serum (AS) 
who had bilateral infectious ulcers positive for Haemophilus influenzae. The patient suffered a 
perforation of his right eye and total healing of his left eye with a residual leukoma. In cases of 
severe malnutrition, serum levels of vitamins and bacteriostatic and growth factors are reduced, 
so AS would not only be ineffective but also increase the risk of secondary corneal infection. 
The prophylactic use of a topical antibiotic would be useful in treatment with AS, especially in 
patients who do not use and adequately store the eye drops, as in our patient.
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Haemophilus influenzae is an uncommon corneal pathogen that generally affects 
  corneas with risk factors;1 it accounts for 2% of all corneal ulcers2. H. influenzae is a 
Gram-negative coccobacillus that infects humans. In ophthalmology, H. influenzae has 
been reported as a cause of endophthalmitis,3 cellulitis, acute bacterial conjunctivitis 
in children,4 and keratitis and scleritis.5
Autologous serum (AS) has been proven effective and safe in the management of 
ocular surface disorders6,7 such as Sjögren’s syndrome,8 persistent epithelial defects,9 
keratoconjunctivitis sicca, and vitamin A deficiency.10
We report the first bilateral case of corneal ulcers infected by H. influenzae due to 
the use of contaminated AS in severe hypovitaminosis A.
Hypovitaminosis A must be suspected in cases of severe dry eye in malnourished 
or alcoholic patients. Although the standard treatment is vitamin supplements, AS has 
been shown to be beneficial.10
Case report
A 38-year-old man with chronic alcoholism and cachexia presented with long-lasting 
watering and burning of the eyes. His corrected visual acuity was 20/20 and he exhibited 
conjunctival keratinization, reduced tear break-up time, moderate superficial keratitis 
punctata, and Schirmer below 5 mm (Figure 1). Blood levels of vitamin E were reduced 
(4.3 mg/L), and those of retinol were undetectable.
After the poor outcomes obtained using treatment with artificial tears and oral 
vitamin A (10,000 IU per day), 20% AS 10 times a day was added.
The protocol followed for AS preparation was as follows: 30 mL of the patient’s 
blood was left to clot at 4°C for 10–12 hours before centrifuging at 4500 rpm for 
15 minutes. The serum was separated in a laminar flow cabinet, diluted with sterile Clinical Ophthalmology 2011:5 submit your manuscript | www.dovepress.com
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saline (0.9%) to a 20% concentration, and aliquoted in 3.0 mL 
portions clearly labeled with the patient’s details. The vials 
should have been kept frozen at −20°C and a fresh bottle 
thawed, stored at 4°C, and used for treatment every week.
After 20 days of treatment, the patient complained of 
loss of bilateral vision. Bilateral infectious ulcers with total 
  hypopion were seen in the oculus dexter (right eye [OD]) and 
infectious ulcers with 2 mm hypopyon in the oculus sinister 
(left eye [OS]) (Figure 1). The patient admitted not storing the 
eye drops at 4°C.
Treatment with topical 3.5% vancomycin, 5% ceftazidime, 
and oral linezolid 600 mg every 12 hours was started. Forty-
eight hours later, the patient had right perforation with 
drainage of purulent content and improvement in his OS 
(Figure 1). The antibiotic schedule was maintained, and 
urgent coating was performed on the amniotic membrane.
Cultures of corneal scraping and AS were positive for 
H. influenzae susceptible to ceftazidime and Staphylococcus 
epidermidis susceptible to vancomycin.
The biochemical analysis of AS resulted in undetectable 
vitamin E and retinol levels. Immunoglobulin and lysozyme 
serum levels were also undetectable. AS was discontinued, 
and oral vitamin supplements were increased (50,000 IU 
per day).
Three weeks later, vitamin A and E serum levels were 
restored; the patient had corrected visual acuity of 16/20 in 
the OS, with residual leukoma not involving the visual axis; 
disappearance of ocular xerophthalmia; and corrected visual 
acuity of the OD for light perception, with good coating of 
the amniotic membrane (Figure 1).
Discussion
AS has been shown to be effective in the management of 
xerophthalmia10 and other ocular surface disorders.6–9 Its main 
advantage is the large amount of nutrients, growth factors, 
and vitamins it contains.7 Its vitamin A levels (46 mg/mL) are 
higher than the levels of umbilical cord serum (0.23 mg/mL) 
and natural (0.02 mg/mL) and artificial tears,7 so AS may be 
useful in vitamin A deficiency.10
However, if serum nutrient levels are low, AS will have the 
same deficiency; in this case we should evaluate its effective-
ness and the need for coadjuvant treatments, or consider the 
possibility of using blood from a donor.
AS drops have a high protein content, so there is a 
significant risk of microbial colonization. Nevertheless, 
toxicity of any added preservatives can negate some of the 
beneficial effects of AS. AS seems to be a safe treatment; it 
does not require preservatives, as it contains bacteriostatic 
factors (immunoglobulins and lysozyme) and has a low risk 
of contamination, provided that preparation and storage 
protocols are followed.11
No severe infections secondary to contaminated AS have 
been reported in previous studies, but indolent infectious 
keratitis has been described. Tananuvat et al studied 15 eyes 
treated with AS and described three infectious ulcers: one 
coagulase-negative Staphylococcus corneal ulcer, one stitch 
abscess without identified organism, and one Candida infec-
tious crystalline keratopathy, although the persistent epithelial 
defect had healed.12 Lagnado et al cultured 134 AS samples; 
13 samples from six patients were positive for S. epidermidis, 
Micrococcus, S. viridans, and S. aureus, all of them without 
clinical repercussion.11
However, in a malnourished subject, serum levels of 
immunoglobulins will be reduced,13 as in our patient, therefore 
increasing the probability for secondary corneal infection.
Furthermore, H. influenzae is an opportunistic pathogen 
with demanding nutritional requirements. It requires factor 
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Figure 1 A) and B) Conjunctival keratinization and moderate superficial keratitis 
punctata. C) Infectious ulcers with total hipopion. D) Infectious ulcers with 2 mm 
hypopion. E) Perforation with drainage of purulent content. F) Improvement of 
infectious keratitis. G) residual leukoma and disappearance of ocular xerophthalmia. 
H) Coating with amniotic membrane.Clinical Ophthalmology
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X and factor V for growth under aerobic conditions.14 Serum 
has no factor I, V , VIII, or XIII. H. influenzae would not grow 
in serum for lack of factor V , but should it be colonized by 
S. epidermidis, as in our case, this would act as a donor of 
factor V , and H. influenzae would grow.
We do not know whether the contamination was due to 
the preparation of the AS or due to inadequate storage of the 
AS by the patient, because the culture was from only one 
AS bottle, the last of the three obtained in the first and only 
blood extraction for AS.
In conclusion, the outcome of this patient suggests two 
major issues. First, if the patient does not adequately use and 
store eye drops, the risk of infection will increase, with the 
appearance of severely infectious keratitis. Therefore, the 
prophylactic use of an antibiotic would be useful. Second, 
in the case of severe malnutrition, serum levels of vitamins 
and bacteriostatic and growth factors would be reduced, so 
AS would not only be ineffective but also increase the risk 
of secondary corneal infection.
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